echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yifan Pharmaceutical's Cefuroxime Sodium for Injection passed the consistency evaluation of generic drugs

    Yifan Pharmaceutical's Cefuroxime Sodium for Injection passed the consistency evaluation of generic drugs

    • Last Update: 2022-05-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    On February 15, Yifan Pharmaceuticals announced that its holding subsidiary, Yifan Yosemite, had recently received a notice from its shareholders and the entrusted pharmaceutical manufacturer Jutai Pharmaceuticals that Yifan Yosemite had all the rights to inject the products under development.
    With cefuroxime sodium, it has been reviewed by the National Center for Drug Evaluation and passed the consistency evaluation of generic drugs


    Cefuroxime sodium for injection is a second-generation cephalosporin antibiotic, mainly used for infections caused by sensitive bacteria, including respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, sepsis, meningitis, gonorrhea, Bone and joint infections, puerperium and gynecological infections

    According to the data from Minet.
    com, the sales of cefuroxime sodium for injection in China in 2019 and 2020 were 5.
    227 billion yuan and 4.
    375 billion yuan respectively


    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.